In clear contrast to this, the AHR response was significantly attenuated in the OVA-immunized/challenged mice that had also been given PS-F2 (Figure 2 and Additional file 1), indicating that PS-F2 treatment suppressed the development of OVA-induced allergic asthma in mice. This evidence concerns the gene AHR and allergic asthma.